摘要:
A semiconductor packaging arrangement, or module, includes a printed circuit board having an electrical interconnect thereon and a semiconductor package mounted to the printed circuit board. The semiconductor package includes a fractional portion of a semiconductor wafer having a plurality of integrated circuit chips thereon, such chips being separated by regions in the fractional portion of the wafer. The fractional portion of the wafer has a plurality of electrical contacts electrically connected to the chips. The package also includes a dielectric member having an electrical conductor thereon. The electrical conductor are electrically connected to the plurality of electrical contacts of the plurality of chips to electrically interconnect such plurality of chips with portions of the electrical conductor spanning the regions in the fractional portion of the wafer. A connector is provided for electrically connecting the electrical conductor of the package to the electrical interconnect of the printed circuit board.
摘要:
Sensing of information from a memory cell via a plateline is disclosed. The memory cell comprises a bitline coupled to a junction of a cell transistor while the other junction is coupled to an electrode of the capacitor. The bitline is coupled to a constant voltage source. A plateline is coupled to the other capacitor electrode.
摘要:
The present invention relates to compounds of the general formula (1) wherein R4 is —SO2R4′, —COOR4″, —COR4′, —CONR4′2 or —CSNR4′2; R4′ is hydrogen, a substituted or unsubstituted alkyl or cycloalkyl residue, a substituted or unsubstituted aryl residue or a saturated or unsaturated, optionally substituted heterocyclic residue; R4″ is a substituted or unsubstituted alkyl or cycloalkyl residue, a substituted or unsubstituted aryl residue or a saturated or unsaturated, optionally substituted heterocyclic residue; L is a sulphonamide, amide, ether, ester, keto, urea, thioether, sulphoxide or sulphone unit optionally extended by one or two methylene groups; and X is N, O or S; and their physiologically acceptable salts and stereoisomers. The present invention furthermore relates to a process for the preparation of the compounds of the formula (1), a pharmaceutical composition containing at least one of these compounds, and the use of compounds of the formula (1) for the production of a pharmaceutical composition having integrin-antagonistic action and in particular for the therapy and prophylaxis of cancer, osteolytic diseases such as osteoporosis, arteriosclerosis, restenosis and ophthalmic disorders.
摘要翻译:本发明涉及通式(1)的化合物,其中R 4是-SO 2 R 4',-COOR 4“,-COR 4', - CONR 4'2或-CSNR 4'2; R 4'是氢,取代或未取代的烷基或环烷基残基,取代或未取代的芳基残基或饱和或不饱和的任选取代的杂环残基; R 4“是取代或未取代的烷基或环烷基残基,取代或未取代的芳基残基或饱和或不饱和的任选取代的杂环残基; L是任选被一个或两个亚甲基延伸的磺酰胺,酰胺,醚,酯,酮,脲,硫醚,亚砜或砜单元; X为N,O或S; 及其生理上可接受的盐和立体异构体。 本发明还涉及制备式(1)化合物的方法,含有这些化合物中的至少一种的药物组合物,以及式(1)化合物在制备药物组合物中的用途 具有整合素拮抗作用,特别是用于治疗和预防癌症,溶骨性疾病如骨质疏松症,动脉硬化,再狭窄和眼科疾病。
摘要:
The present invention relates to compounds of the general formula (1) wherein R4 is —SO2R4, —COOR4′, —COR4′, —CONR4′2 or —CSNR4′2; R4′ is hydrogen, a substituted or unsubstituted alkyl or cycloalkyl residue, a substituted or unsubstituted aryl residue or a saturated or unsaturated, optionally substituted heterocyclic residue; R4″ is a substituted or unsubstituted alkyl or cycloalkyl residue, a substituted or unsubstituted aryl residue or a saturated or unsaturated, optionally substituted heterocyclic residue; L is a sulphonamide, amide, ether, ester, keto, urea, thioether, sulphoxide or sulphone unit optionally extended by one or two methylene groups; and X is N, O or S; and their physiologically acceptable salts and stereoisomers. The present invention furthermore relates to a process for the preparation of the compounds of the formula (1), a pharmaceutical composition containing at least one of these compounds, and the use of compounds of the formula (1) for the production of a pharmaceutical composition having integrin-antagonistic action and in particular for the therapy and prophylaxis of cancer, osteolytic diseases such as osteoporosis, arteriosclerosis, restenosis and ophthalmic disorders.
摘要翻译:本发明涉及通式(1)的化合物,其中R4是-SO2R4,-COOR4',-COR4',-CONR4'2或-CSNR4'2; R 4'是氢,取代或未取代的烷基或环烷基残基,取代或未取代的芳基残基或饱和或不饱和的任选取代的杂环残基; R 4“是取代或未取代的烷基或环烷基残基,取代或未取代的芳基残基或饱和或不饱和的任选取代的杂环残基; L是任选被一个或两个亚甲基延伸的磺酰胺,酰胺,醚,酯,酮,脲,硫醚,亚砜或砜单元; X为N,O或S; 及其生理上可接受的盐和立体异构体。 本发明还涉及制备式(1)化合物的方法,含有这些化合物中的至少一种的药物组合物,以及式(1)化合物在制备药物组合物中的用途 具有整合素拮抗作用,特别是用于治疗和预防癌症,溶骨性疾病如骨质疏松症,动脉硬化,再狭窄和眼科疾病。
摘要:
There is disclosed a tri-state buffer circuit for receiving an input signal at a buffer input node and transmitting, responsive to a buffer enable signal, an output signal at a buffer output node. The buffer circuit includes an input stage coupled to the buffer input node. The input stage is configured to receive, when the buffer enable signal is enabled, the input signal. The buffer circuit further includes a level shifter stage coupled to the input stage. The level shifter stage is arranged to output, when the buffer enable signal is enabled, a set of level shifter stage control signals responsive to the input signal. A voltage range of the set of level shifter stage control signals is higher than a voltage range associated with the input signal. The buffer circuit also includes an output stage coupled to the level shifter stage. The output stage is configured to output, when the buffer enable signal is enabled, the output signal on the buffer output node responsive to the set of level shifter stage control signals. The voltage range of the output signal is lower than the voltage range of the set of level shifter stage control signals. The output stage decouples the buffer output node from the input stage and the level shifter stage when the buffer enable signal is disabled.
摘要:
A process is disclosed for preparing .alpha.-branched aliphatic monocarboxylic acids with 12 to 48 carbon atoms. In a first step of the process (a), .alpha.-branched aliphatic monohydric alcohols (Guerbet alcohols) are converted in the presence of caustic alkali into the alkali salts of the corresponding .alpha.-branched aliphatic monocarboxylic acids. In a second step of the process (b), the .alpha.-branched aliphatic monocarboxylic acids are released from the alkali salts by soap splitting in the presence of an inert diluting agent.
摘要:
Hydraulic oils containing as a base oil at least one Guerbet alcohol of the formula R--OH in which R is a single branched radical containing from 24 to 44 carbon atoms and having an iodine value of from 20 to 150.
摘要:
A method and apparatus for the ablation of hard biological material, such hard dental material, using a rapidly pulsed laser employ a crystal disposed in the propagation path of the laser radiation, the crystal being disposed at the laser output and serving as an interface with an optical conductor which conveys the laser radiation to the treatment site. The crystal smooths the time/intensity characteristics of the pulsed laser radiation to the extent that transmission to the treatment site using optical wave guides is possible. Additional protective features are provided to prevent the ablated biological material to destroy the exposed optical end surfaces of the treatment applicator. Additional design features improve the ergonomic efficiency of the handpiece and its ability to be sterilized.
摘要:
A process of controlling the course of a program in form processing by data processing systems for data contents of a form (80, 81, 82) built of fields to be processed. The pictorial illustration (display of the form (80, 81, 82), the reading and fading in of the data relevant for this form, the manipulation of these data by the user and the processing of these data arranged by the user by a firmly assigned form processing program to the form after selection of a form specification. The form processing program is composed here, under predetermination of the actual form specification, according to the available fields, gradually of individual programs which are typical for the field.
摘要:
The invention is a process for the preparation of elastic polyurethane flexible foams having densities from approximately 25 to 60 kg/m.sup.3, and producing molded articles in closed molds at temperatures from 25.degree. to 80.degree. C., comprising reacting(A) an organic polyisocyanate prepolymer having an isocyanate content from 6 to 20 percent by weight prepared by reacting a toluene diisocyanate and/or a diphenylmethane diisocyanate with a di- to tetrafunctional polyether polyol having a hydroxyl number from 20 to 50 and oxyethylene terminal group content of at least 10 to 30 percent by weight(B) a mixture of compounds containing reactive hydrogen atoms, comprising a mixture of(a) from 55 to 89.5 parts by weight of at least one di- to tetrafunctional polyether polyol having a hydroxyl number of from 20 to 80 and less than 10 percent by weight terminal oxyethylene groups,(b) from 0.5 to 20 parts by weight of at least one alkanolamine, and(c) from 10 to 25 parts by weight water, in the presence of(C) a blowing agent,(D) a catalyst, and optionally(E) auxiliaries and/or additives.
摘要翻译:本发明是制备密度为约25至60kg / m 3的弹性聚氨酯柔性泡沫体的方法,并且在封闭模具中在25℃至80℃的温度下生产模制品,其包括使(A)有机多异氰酸酯 预聚物的异氰酸酯含量为6〜20重量%,其通过使甲苯二异氰酸酯和/或二苯基甲烷二异氰酸酯与羟基数为20至50的二至四官能团聚醚多元醇反应制备,氧乙烯基端基含量为至少10至 30重量%(B)含有反应性氢原子的化合物的混合物,其包含(a)55至89.5重量份的至少一种羟基数为20至80的二官能或四官能团聚醚多元醇的混合物,以及 末端氧乙烯基少于10重量%,(b)0.5至20重量份的至少一种链烷醇胺,和(c)10至25重量份的水, (C)发泡剂,(D)催化剂和任选的(E)助剂和/或添加剂。